Vaagn Andikyan Selected Research

Vaagn Andikyan Research Topics

Disease

22	Neoplasms (Cancer) 04/2024 - 01/2004
6	Ovarian Neoplasms (Ovarian Cancer) 09/2023 - 02/2014
4	Carcinoma (Carcinomatosis) 12/2023 - 10/2021
3	Uterine Cervical Dysplasia 04/2024 - 01/2004
3	Ovarian Epithelial Carcinoma 09/2023 - 02/2014
3	Carcinosarcoma 01/2023 - 01/2022
3	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 11/2009
2	Pain (Aches) 06/2023 - 11/2020
1	Hyperthermia 09/2023
1	Cross Infection (Nosocomial Infection) 05/2023
1	COVID-19 05/2023
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2023
1	Pelvic Floor Disorders 01/2023
1	Microsatellite Instability 01/2022
1	Turcot syndrome 01/2022
1	Disease Progression 10/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2021
1	Nausea 11/2020
1	Neuralgia (Stump Neuralgia) 11/2020
1	Abdominal Pain (Pain, Abdominal) 11/2020
1	Arthralgia (Joint Pain) 11/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 11/2020
1	Intraoperative Complications 07/2016
1	Sarcoma (Soft Tissue Sarcoma) 04/2015
1	Pleural Effusion (Pleural Effusions) 02/2014
1	Thrombocytosis (Thrombocythemia) 11/2009
1	Genetic Predisposition to Disease (Genetic Predisposition) 05/2009
1	Weight Loss (Weight Reduction) 05/2009

Drug/Important Bio-Agent (IBA)

3	PlatinumIBA 03/2024 - 10/2021
3	Immunoconjugates (Immunoconjugate)IBA 12/2023 - 11/2021
3	olaparibIBA 01/2023 - 01/2022
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2013
2	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 03/2024
2	ixabepilone (BMS 247550)FDA Link 03/2024 - 01/2022
2	Bevacizumab (Avastin)FDA Link 03/2024 - 01/2022
2	Topoisomerase I InhibitorsIBA 12/2023 - 01/2023
2	trastuzumab deruxtecanIBA 12/2023 - 01/2023
2	Opioid Analgesics (Opioids)IBA 06/2023 - 11/2020
2	neratinibIBA 01/2023 - 01/2022
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2023 - 01/2022
2	Trastuzumab (Herceptin)FDA Link 11/2021 - 10/2021
2	Carboplatin (JM8)FDA LinkGeneric 10/2021 - 10/2021
2	PorphyrinsIBA 03/2008 - 01/2004
1	copanlisibIBA 04/2024
1	AfatinibIBA 04/2024
1	VaccinesIBA 04/2024
1	Imiquimod (Aldara)FDA LinkGeneric 04/2024
1	Cisplatin (Platino)FDA LinkGeneric 09/2023
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 06/2023
1	SDDSIBA 05/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2022
1	pembrolizumabIBA 01/2022
1	taxaneIBA 01/2022
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 01/2022
1	Adenosine Diphosphate (ADP)IBA 01/2022
1	Alkylating AgentsIBA 11/2021
1	A-Form DNA (A-DNA)IBA 11/2021
1	EpitopesIBA 11/2021
1	pertuzumabIBA 11/2021
1	DHES0815AIBA 11/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2021
1	Medical MarijuanaIBA 11/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2013
1	Indicators and Reagents (Reagents)IBA 11/2009
1	Estrogens (Estrogen)FDA Link 05/2009
1	5-aminolevulinic acid hexyl ester FDA Link 03/2008
1	AcidsIBA 01/2004

Therapy/Procedure

4	Therapeutics 04/2024 - 05/2009
4	Cytoreduction Surgical Procedures 09/2023 - 02/2014
4	Drug Therapy (Chemotherapy) 09/2023 - 11/2021
4	Laparotomy 06/2023 - 11/2012
4	Pelvic Exenteration 10/2013 - 06/2013
3	Hysterectomy 03/2024 - 09/2021
2	Hyperthermic Intraperitoneal Chemotherapy 09/2023 - 10/2021
1	Neoadjuvant Therapy 09/2023
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2023
1	Uterine Myomectomy 04/2015
1	Thoracostomy 02/2014
1	Chest Tubes (Chest Tube) 02/2014
1	Adjuvant Chemotherapy 06/2013
1	Salpingo-oophorectomy 11/2012